Epstein-Barr virus as a possible etiologic agent in primary central nervous system lymphoma in immunocompetent individuals

Neurology India

Volumn 57, Issue 1, 2009, Pages 36-40

  Tandon, Ashwani ^a   Challa, Sundaram ^a   Shanmugam, M ^a   Gopalan, Swarnalatha ^a   Paul, Roshni T ^a   Digumarthi, Raghunadharao ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Epstein Barr virus; Immunocompetent individuals; In situ hybridization; India; Latent membrane protein 1; Primary central nervous system lymphoma

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; LATENT MEMBRANE PROTEIN 1; LEUKOCYTE ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; MALE; OLIGONUCLEOTIDE PROBE; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; T CELL LYMPHOMA;

ADOLESCENT; ADULT; AGED; CENTRAL NERVOUS SYSTEM NEOPLASMS; DNA PRIMERS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOMA; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 63449095108     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.48813     Document Type: Article

References (29)

1. O'Neill BP, Illig JJ. Primary central nervous system lymphoma. Mayo Clin Proc 1989;64:1005-20.
2. DeAngelis LM. Primary central nervous system lymphoma as a secondary malignancy. Cancer 1991;67:431-5.
3. Birx DL, Redfield RR, Tosato G. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N Engl J Med 1986;314:874-9.
4. Yau YH, O'Sullivan MG, Signorini D, Ironside JW, Whittle IR. Primary lymphoma of central nervous system in immunocompetent patients in south-east Scotland. Lancet 1996;348:890.
5. Camilleri-Broet S, Davi F, Feuillard J, Seilhean D, Michiels JF, Brousset P, et al. AIDS-related primary brain lymphomas: Histopathologic and immunohistochemical study of 51 cases. Hum Pathol 1997;28:367-74.
6. Camilleri-Broet S, Martin A, Moreau A, Angonin R, Henin D, Gontier MF, et al. Primary central nervous system lymphomas in 72 immunocompetent patients: Pathologic findings and clinical correlations. Am J Clin Pathol 1998;110:607-12.
7. Powari M, Radotra B, Das A, Banerjee AK. A study of primary central nervous system lymphoma in northern India. Surg Neurol 2002;57:113-6.
8. Sarkar C, Sharma MC, Deb P, Singh R, Santosh V, Shankar SK. Primary central nervous system lymphoma: A hospital based study of incidence and clinicopathological features from India (1980-2003). J Neuro Oncol 2005;71:199-204.
9. Anagnostopoulos I, Hummel M. Epstein-Barr virus in tumours. Histopathology 1996;29:297-315.
10. Agarwal S, Ramanathan U, Naresh KN. Epstein-Barr virus association and ALK gene expression in anaplastic large-cell lymphoma. Hum Pathol 2002;33:146-52.
11. Alderson L, Fetell MR, Sisti M, Hochberg F, Cohen M, Louis DN. Sentinel lesions of primary CNS lymphoma. J Neurol Neurosurg Psychiatry 1996;60:102-5.
12. Niedobitek G, Agathanggelou A, Herbst H, Whitehead L, Wright DH, Young LS. Epstein-Barr virus (EBV) infection in infectious mononucleosis: Virus latency, replication and phenotype of EBV-infected cells. J Pathol 1997;182:151-9.
13. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt?s lymphoma. Lancet 1964;15:702-3.
14. Pallesen G, Hamilton-Dutoit SJ, Zhou X. The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin's disease: Two new developments in the EBV field. Adv Cancer Res 1993;62:79-239.
15. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995;333:693-8.
16. Rea D, Delecluse HJ, Hamilton-Dutoit SJ, Marelle L, Joab I, Edelman L, et al. Epstein-Barr virus latent and replicative gene expression in post- transplant lymphoproliferative disorders and AIDSrelated non-Hodgkin?s lymphomas. Ann Oncol 1994;5:113-6.
17. Glaser SL, Lin RJ, Stewart SL, Ambinder RF, Jarrett RF, Brousset P, et al. Epstein-Barr virus-associated Hodgkin?s disease: Epidemiologic characteristics in international data. Int J Cancer 1997;70:375-82.
18. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985;43:831-40.
19. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985;43:831-40.
20. Johannsen E, Koh E, Mosialos G, Tong X, Kieff E, Grossman SR. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. J Virol 1995;69:253-62.
21. Kulwichit W, Edwards RH, Davenport EM, Baskar JF, Godfrey V, Raab-Traub N. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc Natl Acad Sci U S A 1998;95:11963-8.
22. DeAngelis LM, Wong E, Rosenblum M, Furneaux H. Epstein-Barr virus in acquired immune deficiency syndrome (AIDS) and non-AIDS primary central nervous system lymphoma. Cancer 1992;70:1607-11.
23. Rao CR, Jain K, Bhatia K, Laksmaiah KC, Shankar SK. Association of primary central nervous system lymphomas with the Epstein-Barr virus. Neurol India 2003;51:237-40.
24. Gulley ML. Molecular diagnosis of Epstein Barr virus - related diseases. J Mol Diagn 2001;3:1-10.
25. Jiwa NM, Oudejans JJ, Dukers DF, Vos W, Horstman A, van der Valk P, et al. Immunohistochemical demonstration of different latent membrane protein-1 epitopes of Epstein-Barr virus in lymphoproliferative diseases. J Clin Pathol 1995;48:438-42.
26. Hammer RD, Scott M, Shahab I, Casey TT, Cousar JB, Macon WR. Latent membrane protein antibody reacts with normal hematopoietic precursor cells and leukemic blasts in tissues lacking Epstein-Barr virus genome by polymerase chain reaction. Am J Clin Pathol 1996;106:469-74.
27. Hamilton-Dutoit SJ, Raphael M, Audouin J, Diebold J, Lisse I, Pedersen C, et al. In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: Correlation with tumor morphology and primary site. Blood 1993;82:619-24.
28. Gulley ML, Glaser SL, Craig FE, Borowitz M, Mann RB, Shema SJ, et al. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma. Am J Clin Pathol 2002;117:259-67.
29. Roychowdhury S, Peng R, Baiocchi RA, Bhatt D, Vourganti S, Grecula J, et al. Experimental treatment of Epstein-Barr virusassociated primary central nervous system lymphoma. Cancer Res 2003;63:965-71.